Nicotine is an agonist of nicotinic acetylcholine receptors (nAChRs) that has been extensively used as a template for the synthesis of alpha 4 beta 2-preferring nAChRs. Here, we used the N-methyl-pyrrolidine moiety of nicotine to design and synthesise novel alpha 4 beta 2-preferring neonicotinic ligands. We increased the distance between the basic nitrogen and aromatic group of nicotine by introducing an ester functionality that also mimics acetylcholine (Fig. 2). Additionally, we introduced a benzyloxy group linked to the benzoyl moiety. Although the neonicotinic compounds fully inhibited binding of both alpha-I-125bungarotoxin to human alpha 7 nAChRs and H-3cytisine to human alpha 4 beta 2 nAChRs, they were markedly more potent at displacing radioligand binding to human alpha 4 beta 2 nAChRs than to alpha 7 nAChRs. Functional assays showed that the neonicotinic compounds behave as antagonists at alpha 4 beta 2 and alpha 4 beta 2 alpha 5 nAChRs. Substitutions on the aromatic ring of the compounds produced compounds that displayed marked selectivity for alpha 4 beta 2 or alpha 4 beta 2 alpha 5 nAChRs. Docking of the compounds on homology models of the agonist binding site at the alpha 4/beta 2 subunit interfaces of alpha 4 beta 2 nAChRs suggested the compounds inhibit function of this nAChR type by binding the agonist binding site.
%0 Journal Article
%1 RN130
%A Faundez-Parraguez, M.
%A Farias-Rabelo, N.
%A Gonzalez-Gutierrez, J.P.
%A Etcheverry-Berrios, A.
%A Alzate-Morales, J.
%A Adasme-Carreno, F.
%A Varas, R.
%A Bermudez, I.
%A Iturriaga-Vasquez, P.
%D 2013
%I 2013 Elsevier Ltd.
%J Bioorganic & Medicinal Chemistry
%K acetylcholine affinities, agonists, and antagonism, beta-2 binding, cytisine, docking dqcauchile functional modulators, nicotinic receptors, relationships, sensitivity, structure-activity subunit,
%N 10
%P 2687-2694
%R 10.1016/j.bmc.2013.03.024
%T Neonicotinic Analogues: Selective Antagonists for Alpha 4 Beta 2 Nicotinic Acetylcholine Receptors
%U /brokenurl#<Go to ISI>://WOS:000318318700003
%V 21
%X Nicotine is an agonist of nicotinic acetylcholine receptors (nAChRs) that has been extensively used as a template for the synthesis of alpha 4 beta 2-preferring nAChRs. Here, we used the N-methyl-pyrrolidine moiety of nicotine to design and synthesise novel alpha 4 beta 2-preferring neonicotinic ligands. We increased the distance between the basic nitrogen and aromatic group of nicotine by introducing an ester functionality that also mimics acetylcholine (Fig. 2). Additionally, we introduced a benzyloxy group linked to the benzoyl moiety. Although the neonicotinic compounds fully inhibited binding of both alpha-I-125bungarotoxin to human alpha 7 nAChRs and H-3cytisine to human alpha 4 beta 2 nAChRs, they were markedly more potent at displacing radioligand binding to human alpha 4 beta 2 nAChRs than to alpha 7 nAChRs. Functional assays showed that the neonicotinic compounds behave as antagonists at alpha 4 beta 2 and alpha 4 beta 2 alpha 5 nAChRs. Substitutions on the aromatic ring of the compounds produced compounds that displayed marked selectivity for alpha 4 beta 2 or alpha 4 beta 2 alpha 5 nAChRs. Docking of the compounds on homology models of the agonist binding site at the alpha 4/beta 2 subunit interfaces of alpha 4 beta 2 nAChRs suggested the compounds inhibit function of this nAChR type by binding the agonist binding site.
@article{RN130,
abstract = {Nicotine is an agonist of nicotinic acetylcholine receptors (nAChRs) that has been extensively used as a template for the synthesis of alpha 4 beta 2-preferring nAChRs. Here, we used the N-methyl-pyrrolidine moiety of nicotine to design and synthesise novel alpha 4 beta 2-preferring neonicotinic ligands. We increased the distance between the basic nitrogen and aromatic group of nicotine by introducing an ester functionality that also mimics acetylcholine (Fig. 2). Additionally, we introduced a benzyloxy group linked to the benzoyl moiety. Although the neonicotinic compounds fully inhibited binding of both [alpha-I-125]bungarotoxin to human alpha 7 nAChRs and [H-3]cytisine to human alpha 4 beta 2 nAChRs, they were markedly more potent at displacing radioligand binding to human alpha 4 beta 2 nAChRs than to alpha 7 nAChRs. Functional assays showed that the neonicotinic compounds behave as antagonists at alpha 4 beta 2 and alpha 4 beta 2 alpha 5 nAChRs. Substitutions on the aromatic ring of the compounds produced compounds that displayed marked selectivity for alpha 4 beta 2 or alpha 4 beta 2 alpha 5 nAChRs. Docking of the compounds on homology models of the agonist binding site at the alpha 4/beta 2 subunit interfaces of alpha 4 beta 2 nAChRs suggested the compounds inhibit function of this nAChR type by binding the agonist binding site. },
added-at = {2019-12-04T03:57:35.000+0100},
author = {Faundez-Parraguez, M. and Farias-Rabelo, N. and Gonzalez-Gutierrez, J.P. and Etcheverry-Berrios, A. and Alzate-Morales, J. and Adasme-Carreno, F. and Varas, R. and Bermudez, I. and Iturriaga-Vasquez, P.},
biburl = {https://www.bibsonomy.org/bibtex/2453273b56e1bc92b375ec76ed224b827/dqcauchile},
doi = {10.1016/j.bmc.2013.03.024},
interhash = {687fdb7a374c953d5886b4f7c87b7f9d},
intrahash = {453273b56e1bc92b375ec76ed224b827},
issn = {0968-0896},
journal = {Bioorganic & Medicinal Chemistry},
keywords = {acetylcholine affinities, agonists, and antagonism, beta-2 binding, cytisine, docking dqcauchile functional modulators, nicotinic receptors, relationships, sensitivity, structure-activity subunit,},
number = 10,
pages = {2687-2694},
publisher = {2013 Elsevier Ltd.},
timestamp = {2019-12-04T03:58:17.000+0100},
title = {Neonicotinic Analogues: Selective Antagonists for Alpha 4 Beta 2 Nicotinic Acetylcholine Receptors},
type = {Journal Article},
url = {/brokenurl#<Go to ISI>://WOS:000318318700003},
volume = 21,
year = 2013
}